A Study of Durvalumab (Anti-PDL1) Plus Radiation Therapy for the Treatment of Solitary Bone Plasmacytoma
Clinical trial NCT03196401 · WITHDRAWN
Trial details
- NCT number
- NCT03196401
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-27
- Primary completion
- 2020-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.